Serum cytokines and bone metabolic markers in patients with rheumatoid arthritis treated with biological disease modifying anti-rheumatic drugs.
Hiroya TamaiNaoshi NishinaJun KikuchiKeisuke IzumiKotaro OtomoKeiko YoshimotoKunihiro YamaokaTsutomu TakeuchiYuko KanekoPublished in: Clinical rheumatology (2022)
bDMARDs with different modes of action exert different effects on the cytokine and bone metabolic marker levels in patients with RA.